Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP738841.RAK5xGRhC-O773zk0UBFK1pxrS449638eQb7Va4o4TV84130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP738841.RAK5xGRhC-O773zk0UBFK1pxrS449638eQb7Va4o4TV84130_assertion type Assertion NP738841.RAK5xGRhC-O773zk0UBFK1pxrS449638eQb7Va4o4TV84130_head.
- NP738841.RAK5xGRhC-O773zk0UBFK1pxrS449638eQb7Va4o4TV84130_assertion description "[Preliminary in vitro and in vivo studies with valproic acid (VPA) in cell lines and patients with spinal muscular atrophy (SMA) demonstrate increased expression of SMN, supporting the possibility of therapeutic benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738841.RAK5xGRhC-O773zk0UBFK1pxrS449638eQb7Va4o4TV84130_provenance.
- NP738841.RAK5xGRhC-O773zk0UBFK1pxrS449638eQb7Va4o4TV84130_assertion evidence source_evidence_literature NP738841.RAK5xGRhC-O773zk0UBFK1pxrS449638eQb7Va4o4TV84130_provenance.
- NP738841.RAK5xGRhC-O773zk0UBFK1pxrS449638eQb7Va4o4TV84130_assertion SIO_000772 19440247 NP738841.RAK5xGRhC-O773zk0UBFK1pxrS449638eQb7Va4o4TV84130_provenance.
- NP738841.RAK5xGRhC-O773zk0UBFK1pxrS449638eQb7Va4o4TV84130_assertion wasDerivedFrom befree-2016 NP738841.RAK5xGRhC-O773zk0UBFK1pxrS449638eQb7Va4o4TV84130_provenance.
- NP738841.RAK5xGRhC-O773zk0UBFK1pxrS449638eQb7Va4o4TV84130_assertion wasGeneratedBy ECO_0000203 NP738841.RAK5xGRhC-O773zk0UBFK1pxrS449638eQb7Va4o4TV84130_provenance.